ANDREEA BARCAN: Open Payments
NPI 1326483199 · NAPLES, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,275 in 109 payments from 17 companies in 2025. Trend: 2023 $1,554 · 2024 $2,353 · 2025 $2,275
Food & beverage: $2,202Education: $73
| Company | Payments | Amount |
|---|---|---|
| Eisai Inc. | 13 | $469 |
| ABBVIE INC. | 38 | $469 |
| UCB, Inc. | 15 | $279 |
| Teva Pharmaceuticals USA, Inc. | 13 | $254 |
| Lilly USA, LLC | 8 | $239 |
| Lundbeck LLC | 7 | $158 |
| Biogen, Inc. | 1 | $125 |
| GE HEALTHCARE | 3 | $74 |
| Neurelis, Inc. | 2 | $41 |
| Janssen Biotech, Inc. | 2 | $37 |
Products named: Leqembi, QULIPTA, Zilbrysq, AUSTEDO XR, VUMERITY, KISUNLA, UBRELVY, AMYVID.
Industry payments across FL — which companies pay providers there.
